Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 150

Results For "IP"

10305 News Found

Antara Senior Care launches second Chennai care home amid growing senior population
News | February 10, 2026

Antara Senior Care launches second Chennai care home amid growing senior population

The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity


Ajooni Biotech bags record Rs. 47.52 crore order
Biotech | February 10, 2026

Ajooni Biotech bags record Rs. 47.52 crore order

The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production


Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
Supply Chain | February 10, 2026

Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics

Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions


Zydus Lifesciences reports strong Q3 & 9M FY26 growth
News | February 10, 2026

Zydus Lifesciences reports strong Q3 & 9M FY26 growth

Revenue from operations surged 30% year-on-year to Rs. 68,645 million


GSK India crosses Rs. 1,000 crore mark, key portfolios drive 8.1% topline growth
News | February 10, 2026

GSK India crosses Rs. 1,000 crore mark, key portfolios drive 8.1% topline growth

Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum


Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26
News | February 10, 2026

Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26

The revenues this quarter are in line with the outlook we envisaged for the year


Time Medical India unveils next-generation MRI platforms at IRIA 2026
News | February 10, 2026

Time Medical India unveils next-generation MRI platforms at IRIA 2026

The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology


SMS Pharmaceuticals posts strong Q3 with 29% PAT growth, full-year targets on track
News | February 10, 2026

SMS Pharmaceuticals posts strong Q3 with 29% PAT growth, full-year targets on track

The company’s EBITDA margin remained resilient above 20%


Jubilant Pharmova posts robust Q3, eyes Vision 2030 with sterile injectables drive
News | February 09, 2026

Jubilant Pharmova posts robust Q3, eyes Vision 2030 with sterile injectables drive

The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses